Water Soluble Furoxan Derivatives as NO Prodrugs
- 1 February 1997
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (4) , 463-469
- https://doi.org/10.1021/jm960379t
Abstract
The synthesis, characterization, NO donor properties, and in vitro vasodilating activity of a series of water soluble furoxans (5-14a,b) are described. All of the compounds released NO when treated with a large excess of cysteine under physiological conditions (pH 7.4; 37 degrees C). The amount of NO produced after 1 h of incubation was evaluated by detecting nitrites, via the Griess reaction. Derivatives 5b, 7b, and 14b were able to release nitric oxide also in the absence of the thiol cofactor. The initial rates of NO release were determined at different concentrations, using a spectrophotometric technique based on the NO-induced oxidation of oxyhemoglobin (HbO2) to methemoglobin (MetHb). The initial rates of NO release were linearly dependent on the concentrations of the single compounds. The vasodilating potency (EC50) of all the derivatives was assessed on rat aortic strips precontracted with noradrenaline. Correlation between potency and initial NO release rate is discussed.This publication has 15 references indexed in Scilit:
- The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363British Journal of Pharmacology, 1996
- The Furoxan System as a Useful Tool for Balancing "Hybrids" with Mixed .alpha.1-Antagonist and NO-like Vasodilator ActivitiesJournal of Medicinal Chemistry, 1995
- Nitric Oxide: A New Paradigm for Second MessengersJournal of Medicinal Chemistry, 1995
- Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donorBritish Journal of Pharmacology, 1995
- Nitric Oxide-based Possibilities for PharmacotherapyAnnals of Medicine, 1995
- Furoxans as Nitric Oxide Donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-Mediated Nitric Oxide Release and Biological EvaluationJournal of Medicinal Chemistry, 1994
- CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donorEuropean Journal of Pharmacology, 1994
- Therapeutic role of nitric oxide donors in the treatment of cardiovascular diseaseDrugs of the Future, 1994
- Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxansBiochemical Pharmacology, 1992
- Characterization of a new compound, S35b, as a guanylate cyclase activator in human plateletsBiochemical Pharmacology, 1992